Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-07-19
2011-07-19
Kumar, Shailendra (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
07981936
ABSTRACT:
The invention is directed to the Form A polymorph of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide and its use as a therapeutic/cosmetic agent.
REFERENCES:
patent: 4299845 (1981-11-01), Loebenberg et al.
patent: 6133326 (2000-10-01), Mayne
patent: 2005/0079144 (2005-04-01), Kostlan et al.
patent: 0 433 622 (1991-06-01), None
patent: 0 699 439 (1996-03-01), None
patent: WO 01/56556 (2001-08-01), None
patent: WO 2005/035931 (2005-04-01), None
Yagyu et al.,Absence of ACAT-1 Attenuates Atherosclerosis but Causes Dry Eye and Cutaneous Xanthomatosis in Mice with Congenital Hyperlipidemia, Journal of Biological Chemistry, vol. 275/28, pp. 21324-21330.
Graceway Pharmaceuticals, LLC
Kumar Shailendra
McDermott Will & Emery LLP
LandOfFree
Crystalline ACAT inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline ACAT inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline ACAT inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701268